Loading…
CORONA Remedies (CORONA)₹2,539+0.21%Pharmaceuticals
At the end of the Sep 2026 quarter, CORONA Remedies' shareholders were: promoters 69.05%, FIIs 4.22%, DIIs 16.48%, public 10.25%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 21,100 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|
| Promoters | 69.05% | 69.05% | 69.05% | 69.05% |
| FIIs | 1.85% | 2.26% | 3.64% | 4.22% |
| DIIs | 6.81% | 7.06% | 12.94% | 16.48% |
| Public | 22.29% | 21.63% | 14.37% | 10.25% |
| Promoter shares pledged | — | — | — | 0.00% |
| Number of shareholders | 31,038 | 19,611 | 20,187 | 21,100 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Ankurbhai K Mehta | Promoter | 22.05% | 0.00 |
| Nirav Kirtikumar Mehta | Promoter | 21.95% | 0.00 |
| Kirtikumar Laxmidas Mehta | Promoter | 19.99% | 0.00 |
| Sepia Investments Limited | Public | 8.59% | −4.06 |
| Invesco India Small Cap Fund | DII | 5.21% | +0.20 |
| Hdfc Trustee Company Limited-Hdfc Flexi Cap Fund | DII | 4.12% | 0.00 |
| Sbi Retirement Benefit Fund- Conservative Plan | DII | 3.56% | New |
| Brinda Ankur Mehta | Promoter | 1.99% | 0.00 |
| Dipaben Niravkumar Mehta | Promoter | 1.99% | 0.00 |
| Minaxi Kirtikumar Mehta | Promoter | 0.99% | 0.00 |
Promoters held 69.05% of CORONA Remedies at the end of the Sep 2026 quarter.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 4.22% (up 0.58 percentage points from 3.64% a quarter earlier) and domestic institutions (DIIs) held 16.48% (up 3.54 percentage points from 12.94% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
CORONA Remedies had 21,100 shareholders at the end of the Sep 2026 quarter.
Sepia Investments Limited (Public) held 8.59% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.